Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared Emmanuel J Favaloro‘s post on LinkedIn, adding:
”Pleased to see our recent work on Emicizumab in Acquired Hemophilia A published in Seminars in Thrombosis and Hemostasis and shared by the Editor-in-Chief, Prof. Emmanuel J. Favaloro.
In this study we report real-world clinical experience and patient-level outcomes on the use of Emicizumab in a rare and complex bleeding disorder.
Our findings highlight its potential role in improving bleeding control and reducing hospitalization in selected patients with Acquired Hemophilia A.
Rare diseases require rigorous research, careful clinical judgment, and strong collaboration across centers.
Grateful to all colleagues who contributed to this work.”
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn about a recent article by Ilenia Calcaterra et al, published in Seminars in Thrombosis and Hemostasis:
”Emicizumab in Acquired Hemophilia A.
Recently released online in Seminars in Thrombosis and Hemostasis.
Enjoy!”
Title: Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis
Authors: Ilenia Calcaterra, Carmine De Luca, Guido D’Errico, Ciro Miele, Chiara Caputo, Raffaele Russo, Paolo Conca, Ernesto Cimino, Anna Guida, Antonella Tufano, Matteo Di Minno
Read the Full Article on Seminars in Thrombosis and Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers
-
Nov 5, 2026, 13:48David McIntosh: Plasma Progress – Reaching the 80% of Patients Still Left Behind
-
Nov 5, 2026, 13:42Hélène Gleitz-Broeders: How MPNs Reshape the Bone Marrow Microenvironment
-
Nov 5, 2026, 13:40Augustina Isioma Ikusemoro: The Role of Blood Conservation in PBM
-
Nov 5, 2026, 13:36Vera Ignjatović: Paediatric Thrombosis and Haemostasis Takes Centre Stage in Serbia